AnPac Bio-Medical Science Co., Ltd.
ANPC · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2 | $9 | $3 | $6 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $6 | $6 | $9 | $2 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $8 | $9 | $14 |
| Total Curr. Assets | $14 | $24 | $21 | $22 |
| Property Plant & Equip (Net) | $24 | $20 | $19 | $19 |
| Goodwill | $0 | $13 | $2 | $2 |
| Intangibles | $1 | $10 | $6 | $6 |
| Long-Term Investments | $1 | $1 | $1 | $2 |
| Tax Assets | $0 | -$2 | $0 | $0 |
| Other NC Assets | $0 | $2 | $0 | $1 |
| Total NC Assets | $27 | $44 | $29 | $31 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $40 | $67 | $50 | $53 |
| Liabilities | – | – | – | – |
| Payables | $2 | $3 | $2 | $2 |
| Short-Term Debt | $6 | $34 | $8 | $39 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $5 | $4 | $4 | $2 |
| Other Curr. Liab. | $29 | $22 | $29 | $23 |
| Total Curr. Liab. | $42 | $63 | $44 | $66 |
| LT Debt | $7 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $2 | $1 | $1 |
| Other NC Liab. | $1 | $1 | $2 | $2 |
| Total NC Liab. | $8 | $3 | $3 | $3 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $50 | $66 | $47 | $69 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $6 | $1 | $1 | $1 |
| Retained Earnings | -$578 | -$476 | -$357 | -$276 |
| AOCI | $4 | $5 | $5 | $2 |
| Other Equity | $554 | $465 | $354 | -$19 |
| Total Equity | -$14 | -$4 | $3 | -$16 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $4 | $6 | $0 | $0 |
| Total Liab. & Tot. Equity | $40 | $67 | $50 | $53 |
| Net Debt | $10 | $25 | $5 | $32 |